Cypress Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.31M | Buy |
4,016
+100
| +3% | +$31.7K | 0.29% | 63 |
|
|
2025
Q3 | $1.11M | Buy |
3,916
+79
| +2% | +$22.9K | 0.25% | 67 |
|
|
2025
Q2 | $1.07M | Buy |
3,837
+20
| +0.5% | +$5.67K | 0.26% | 66 |
|
|
2025
Q1 | $1.19M | Sell |
3,817
-12
| -0.3% | -$3.54K | 0.32% | 62 |
|
|
2024
Q4 | $1.03M | Sell |
3,829
-105
| -3% | -$31.2K | 0.25% | 67 |
|
|
2024
Q3 | $1.27M | Buy |
3,934
+116
| +3% | +$37.9K | 0.32% | 65 |
|
|
2024
Q2 | $1.23M | Sell |
3,818
-459
| -11% | -$135K | 0.32% | 64 |
|
|
2024
Q1 | $1.25M | Buy |
4,277
+555
| +15% | +$162K | 0.34% | 63 |
|
|
2023
Q4 | $1.07M | Sell |
3,722
-15
| -0.4% | -$4.09K | 0.32% | 70 |
|
|
2023
Q3 | $998K | Buy |
3,737
+25
| +0.7% | +$6.24K | 0.33% | 69 |
|
|
2023
Q2 | $846K | Buy |
3,712
+145
| +4% | +$33.6K | 0.27% | 78 |
|
|
2023
Q1 | $862K | Buy |
3,567
+30
| +0.8% | +$7.36K | 0.3% | 81 |
|
|
2022
Q4 | $929K | Sell |
3,537
-75
| -2% | -$20.1K | 0.34% | 78 |
|
|
2022
Q3 | $814K | Sell |
3,612
-85
| -2% | -$20.6K | 0.31% | 77 |
|
|
2022
Q2 | $899K | Sell |
3,697
-185
| -5% | -$45.3K | 0.32% | 76 |
|
|
2022
Q1 | $939K | Sell |
3,882
-1,065
| -22% | -$245K | 0.28% | 81 |
|
|
2021
Q4 | $1.11M | Sell |
4,947
-2,241
| -31% | -$473K | 0.26% | 85 |
|
|
2021
Q3 | $1.53M | Sell |
7,188
-620
| -8% | -$143K | 0.4% | 72 |
|
|
2021
Q2 | $1.9M | Sell |
7,808
-2,470
| -24% | -$608K | 0.49% | 64 |
|
|
2021
Q1 | $2.56M | Sell |
10,278
-959
| -9% | -$229K | 0.71% | 49 |
|
|
2020
Q4 | $2.58M | Sell |
11,237
-85
| -0.8% | -$19.6K | 0.72% | 46 |
|
|
2020
Q3 | $2.88M | Sell |
11,322
-44
| -0.4% | -$10.9K | 0.9% | 36 |
|
|
2020
Q2 | $2.68M | Sell |
11,366
-505
| -4% | -$115K | 0.89% | 37 |
|
|
2020
Q1 | $2.41M | Sell |
11,871
-10
| -0.1% | -$2.18K | 1.04% | 29 |
|
|
2019
Q4 | $2.86M | Sell |
11,881
-560
| -5% | -$123K | 0.98% | 31 |
|
|
2019
Q3 | $2.41M | Sell |
12,441
-100
| -0.8% | -$19.2K | 0.83% | 38 |
|
|
2019
Q2 | $2.31M | Buy |
12,541
+340
| +3% | +$60.9K | 0.79% | 41 |
|
|
2019
Q1 | $2.32M | Buy |
12,201
+11,001
| +917% | +$2.1M | 0.79% | 41 |
|
|
2018
Q4 | $234K | Hold |
1,200
| – | – | 0.09% | 142 |
|
|
2018
Q3 | $249K | Sell |
1,200
-10
| -0.8% | -$1.97K | 0.07% | 163 |
|
|
2018
Q2 | $223K | Hold |
1,210
| – | – | 0.07% | 167 |
|
|
2018
Q1 | $206K | Sell |
1,210
-140
| -10% | -$25.7K | 0.06% | 168 |
|
|
2017
Q4 | $235K | Sell |
1,350
-15
| -1% | -$2.65K | 0.05% | 172 |
|
|
2017
Q3 | $255K | Sell |
1,365
-10
| -0.7% | -$1.77K | 0.05% | 168 |
|
|
2017
Q2 | $237K | Sell |
1,375
-25
| -2% | -$4.07K | 0.05% | 180 |
|
|
2017
Q1 | $230K | Sell |
1,400
-100
| -7% | -$16.6K | 0.04% | 199 |
|
|
2016
Q4 | $219K | Sell |
1,500
-50
| -3% | -$7.53K | 0.04% | 202 |
|
|
2016
Q3 | $259K | Buy |
1,550
+125
| +9% | +$21.1K | 0.05% | 181 |
|
|
2016
Q2 | $217K | Sell |
1,425
-75
| -5% | -$11.7K | 0.04% | 188 |
|
|
2016
Q1 | $225K | Buy |
1,500
+50
| +3% | +$7.43K | 0.05% | 180 |
|
|
2015
Q4 | $235K | Buy |
+1,450
| New | +$228K | 0.05% | 175 |
|
|
2015
Q3 | – | Sell |
-1,400
| Closed | -$215K | – | 191 |
|
|
2015
Q2 | $215K | Buy |
+1,400
| New | +$224K | 0.04% | 190 |
|
Other funds holding AMGN
Cypress Asset Management's AMGN Position: Q4 2025 in Review
Cypress Asset Management increased its Amgen (AMGN) stake by 2.6% in Q4 2025, buying an estimated $31.7K and bringing the position to 4,016 shares worth $1.31M. The position accounts for 0.29% of the portfolio, ranked #63.
Cypress Asset Management first reported a position in AMGN in Q2 2015 and has held it in 42 quarters since. The position peaked at $2.88M in Q3 2020. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Cypress Asset Management held 4,016 shares of Amgen worth $1.31M as of Q4 2025.
- Cypress Asset Management bought 100 Amgen shares in Q4 2025, an estimated $31.7K.
- Amgen made up 0.29% of Cypress Asset Management's portfolio in Q4 2025, its #63 holding.
- Cypress Asset Management first reported a position in Amgen in Q2 2015 and has held it in 42 quarters since.
- Cypress Asset Management's Amgen position peaked at $2.88M in Q3 2020.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Cypress Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.